Leading oncology drug developers raise $67 million in funding to target cancer's vulnerability to oncogene overactivation.

Future research could identify drugs that can target this newfound brain circuit to help treat a vast range of immune ...

Scientists at Harvard Medical School have used technology from Opentrons Labworks to streamline sample preparation.

The Producer service offers customers a second option for accessing Asimov's technology for the cell and gene therapy ...

The U.S. Human Proteome Organization presides over Proteinlandia, where cutting-edge research and emerging technologies get a ...

When asked about the most challenging part of turning TILs into therapies, it is expanding a sample into billions of cells.

Vaccine harnesses multi-lamellar LP aggregates (LPA) that can simultaneously function as vaccines and as immunomodulating agents.

Disrupting the gut microbiome of male mice increases the probability that their offspring are born with low weight and will die prematurely.

NIIMBL’s mission is to accelerate biopharmaceutical innovation, support development of manufacturing standards, and boost workforce skills.

Ribosome sequences in the genomes of biomanufacturing strains could be manipulated to increase recombinant protein synthesis yields.

AAV and LVV cover the entire vector manufacturing process, from transfection to purification, as well as suspension and adherent processes.

Researchers at the Karolinska Institute may have found a new way to treat obesity and related disorders by targeting the ...